These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21366655)

  • 1. A case of sulphasalazine potentiating the hypoprothombinemic effect of warfarin resulting in bleeding.
    Hall S; Rindone JP
    J Clin Pharm Ther; 2011 Apr; 36(2):246-8. PubMed ID: 21366655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin-cranberry juice interaction resulting in profound hypoprothrombinemia and bleeding.
    Rindone JP; Murphy TW
    Am J Ther; 2006; 13(3):283-4. PubMed ID: 16772772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probable interaction between warfarin and marijuana smoking.
    Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
    Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan potentiation of warfarin effect.
    Huang SS; Sung SH; Chiang CE
    Ann Pharmacother; 2007 Nov; 41(11):1912-4. PubMed ID: 17925502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle.
    Kucher N; Connolly S; Beckman JA; Cheng LH; Tsilimingras KV; Fanikos J; Goldhaber SZ
    Arch Intern Med; 2004 Oct; 164(19):2176-9. PubMed ID: 15505133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin therapy: evolving strategies in anticoagulation.
    Horton JD; Bushwick BM
    Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH; Wheeldon NM
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated international normalized ratio associated with use of dronedarone and warfarin.
    Pogge EK; Haber SL
    Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of warfarin anticoagulation associated with topical methyl salicylate.
    Joss JD; LeBlond RF
    Ann Pharmacother; 2000 Jun; 34(6):729-33. PubMed ID: 10860133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalent aetiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics.
    Cryder B; Felczak M; Janociak J; Dela Pena L; Allen S; Gutierrez P
    J Clin Pharm Ther; 2011 Feb; 36(1):64-70. PubMed ID: 21198721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of Warfarin Associated with Salsalate Therapy Resulting in Bleeding.
    Rindone JP; Mellen CK
    Curr Drug Saf; 2018; 13(2):141-143. PubMed ID: 29468979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.
    Christopher A
    Ann Pharmacother; 2011 Nov; 45(11):e58. PubMed ID: 22010004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.